NCT03530202 is a Phase 2 clinical trial of Creatine monohydrate in Sarcopenia, sponsored by University of Regina.

Who is sponsoring NCT03530202?

NCT03530202 is sponsored by University of Regina.

What drugs are being tested in NCT03530202?

Interventions in NCT03530202: Creatine monohydrate, Maltodextrin Powder.

What condition does NCT03530202 study?

NCT03530202 studies Sarcopenia.

Is NCT03530202 still recruiting?

NCT03530202 is currently status unknown. Last updated 21 May 2018.

Last reviewed 2018-05-21 · How we verify

NCT03530202

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of High-velocity Resistance Training and Creatine Supplementation in Healthy Aging Males

Status unknown Phase 2 Last updated 21 May 2018

What this trial tests

Phase 2 trial testing Creatine monohydrate in Sarcopenia in 40 participants. Status unknown.

Timeline

1 January 2018

Primary endpoint
31 July 2018

31 July 2018

Quick facts

Lead sponsor	University of Regina
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	40
Start date	1 January 2018
Primary completion	31 July 2018
Estimated completion	31 July 2018
Sites	1 location across Canada

Drugs / interventions tested

Creatine monohydrate — full drug profile →
Maltodextrin Powder

Conditions studied

Sarcopenia — all drugs for Sarcopenia →

Sponsor

University of Regina

Who can join

50 and older, male only, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The age-related loss of skeletal muscle mass (i.e. sarcopenia)and muscle performance (i.e. strength and power), decreases functionality and the ability to perform activities of daily living. Therefore, lifestyle interventions which may improve aging muscle health are important (i.e. resistance training and creatine supplementation). High-velocity resistance training (HVRT) has been shown to increase muscle mass and muscle performance in aging adults. Creatine (CR), a compound naturally found in red meat and seafood, has also been shown to increase muscle mass and muscle performance in aging adults. No study has examined the combined effects of HVRT and CR supplementation in aging adults. This study may determine whether this lifestyle intervention is effective to combat sarcopenia.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Development of Pharmacotherapies for the Treatment of Sarcopenia.
Rooks D, Roubenoff R. · · 2019 · cited 27× · PMID 31237312 · DOI 10.14283/jfa.2019.11
Targeting Crosstalk of Signaling Pathways among Muscles-Bone-Adipose Tissue: A Promising Therapeutic Approach for Sarcopenia.
Sharma AR, Chatterjee S, Lee YH, Lee SS. · · 2024 · cited 10× · PMID 37815907 · DOI 10.14336/ad.2023.00903
Receptor-Mediated Muscle Homeostasis as a Target for Sarcopenia Therapeutics.
Yoon JH, Kwon KS. · · 2021 · cited 8× · PMID 34218646 · DOI 10.3803/enm.2021.1081

Verify or expand the search:

Other trials of Creatine monohydrate

Trials testing the same drug.

NCT07310043 — Creatine and Perioperative Brain Health · NA · not yet recruiting
NCT06992414 — Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19 · NA · not yet recruiting
NCT06576466 — Effect of Supplementation With Creatine on the Recovery of Ischemic Stroke · NA · recruiting
NCT06438887 — Strategic Ingestion of Creatine Supplementation and Resistance Training in Trained Young Adults · NA · recruiting
NCT04395183 — 5-HTP and Creatine for Depression · Phase 2 · completed

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other University of Regina trials

Trials by the same sponsor.

NCT06020274 — Internet-delivered Cystic Fibrosis Mental Health Prevention, Wellness, Resource Program: How Does it Work? · NA · not yet recruiting
NCT07021053 — Adaptive Actions and Alcohol Use Outcomes During Internet-delivered Cognitive Behaviour Therapy · NA · recruiting
NCT07021183 — The Public Safety Personnel (PSP) Sleep Course: An Online Sleep Intervention for PSP. · NA · recruiting
NCT06881693 — Internet-Delivered Cognitive Behaviour Therapy for Depression and Anxiety in Perinatal Parents · NA · recruiting
NCT06606704 — Effects of Resistance-band Training and Creatine Supplementation Strategies in Healthy Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03530202 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Regina
Last refreshed: 21 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03530202.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing